Paragon 28 Cruises in First Year Post-IP
The company grew 23% in 2022, its first year as a publicly traded company. New products and sales force expansion drove the growth. Mar 03, 2023
ATEC Takes Leap Forward in 2022
The company grew more than 44% in 2022 through its sole focus on spine surgery. ATEC expects to grow another 25% in 2023. Mar 02, 2023
Conformis Product Revenue Slips in 2022
The company's product revenue declined in the low single digits in 2022 as it transforms its business model and contends with supply issues. Mar 02, 2023
SI-BONE Soars on Accelerating Demand
The company grew 18% in 2022, driven by accelerating demand momentum in its core SI-fusion business and increased surgeon engagement. Mar 01, 2023
Too Big to Grow in the Spine Market?
Our chart of the month shows the projected top 10 largest players in spine after recent M&A deals in the market segment. Feb 28, 2023
Vericel’s MACI Primed for Growth
The company's MACI sales grew more than 18% for FY22 and greatly accelerated its path toward a new arthroscopic delivery method. Feb 28, 2023
Orthopedic Execs Talk Tech, M&A and Surgical Volumes
Ortho execs on enabling technology’s important role in implant sales, recent M&A deals that worked and improving surgical procedure volumes. Feb 27, 2023
Enovis Flourishes in First Year as Stand-Alone
Enovis reported 4Q22 orthopedic sales of $162.5 million, +10.4% compared to 4Q21. Including contributions from acquisitions, the company generated $599.4... Feb 27, 2023
Medtronic’s Arsenal of Technology Driving Growth
The company's reported orthopedic sales grew by low-single digits during the third quarter of its 2023 fiscal year. Feb 27, 2023
3 Market Trends in Joint Replacement
New technologies, increasing cementless adoption and volume-based procurement in China set the stage for a dynamic year in joint replacement. Feb 24, 2023
